Unveiling the role of Daam1 gene in intestinal stem cell fate decisions

Stem cells can differentiate to replace dead and damaged cells. But how do stem cells decide which type of cell to become in a given situation?

Editas and Genevant team up to develop gene editing therapies – Pharmaceutical Technology

Genevant LNP technology will provide a vehicle for Editas’ CRISPR/Cas12a gene therapy. Credit: ART-ur / Shutterstock. Editas Medicine and Genevant Sciences will collaborate to develop

October 22, 2024

Chickpea’s secret history: How trade routes and migrations shaped the legume’s genetic heritage

With its nutty flavor and dense nutrient profile, the humble chickpea has captivated palates and nourished civilizations for millennia.

June 23, 2023

Abbott ramps up over-the-counter CGM race with new sensors

Dive Brief: Abbott said Monday it will launch two over-the-counter continuous glucose monitors after receiving clearance from the Food and Drug Administration. One product is

June 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.